
1. sci rep. 2013 nov 25;3:3318. doi: 10.1038/srep03318.

genome-wide screen identifies new candidate genes associated artemisinin
susceptibility plasmodium falciparum kenya.

borrmann s(1), straimer j, mwai l, abdi a, rippert a, okombo j, muriithi s, sasi 
p, kortok mm, lowe b, campino s, assefa s, auburn s, manske m, maslen g, peshu n,
kwiatkowski dp, marsh k, nzila a, clark tg.

author information: 
(1)1] kemri-wellcome trust research programme, kilifi, kenya [2] institute of
microbiology, magdeburg university school medicine, germany.

early identification causal genetic variants underlying antimalarial drug
resistance could provide robust epidemiological tools timely public health
interventions. using novel natural genetics strategy mapping novel
candidate genes analyzed >75,000 high quality single nucleotide polymorphisms 
selected high-resolution whole-genome sequencing data 27 isolates of
plasmodium falciparum. identified genetic variants associated with
susceptibility dihydroartemisinin implicate one region chromosome 13, 
a candidate gene chromosome 1 (pfa0220w, ubp1 ortholog) others
(pfb0560w, pfb0630c, pff0445w) putative roles protein homeostasis and
stress response. strong signal positive selection pfa0220w,
but candidate loci. results demonstrate power of
full-genome sequencing-based association studies uncovering candidate genes
that determine parasite sensitivity artemisinins. study provides unique 
reference interpretation results resistant infections.

doi: 10.1038/srep03318 
pmcid: pmc3839035
pmid: 24270944  [indexed medline]

